Akzo Nobel India Board of Directors

Get the latest insights into the leadership at Akzo Nobel India. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rajiv Rajgopal Chairman & Managing Director
Mr. Krishna Rallapalli WholeTime Director & CFO
Mr. Rohit G Totla Whole Time Director
Mr. Hemant Sahai Independent Director
Mr. Anil Chaudhry Independent Director
Ms. Namrata Kaul Independent Director

Akzo Nobel India Share price

AKZOINDIA

3417.2

43.60 (1.29%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High

3429.00

Today's Low

3380.20

52 Week Low

3022.00

52 Week High

4674.00

The current prices are delayed, login to your account for live prices

Akzo Nobel India FAQs

The board at Akzo Nobel India consists of experienced professionals, including Mr. Rajiv Rajgopal , Mr. Krishna Rallapalli , and others, overseeing the company’s strategic and corporate governance.

Directors at Akzo Nobel India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rajiv Rajgopal is the current chairman at Akzo Nobel India.

Executive directors at Akzo Nobel India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Akzo Nobel India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Akzo Nobel India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.